O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial

K. Fuh, D. Richardson, R. Arend, C. McCourt, A. Hagemann, M. Liang, Laura Holman, C. Washington, J. Walker, R. Mannel, Grace Youn, D. Mutch, W. Huh, A. Cohoon, Charles Leath Iii, M. Powell, Camille Gunderson-Jackson, K. Moore
{"title":"O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial","authors":"K. Fuh, D. Richardson, R. Arend, C. McCourt, A. Hagemann, M. Liang, Laura Holman, C. Washington, J. Walker, R. Mannel, Grace Youn, D. Mutch, W. Huh, A. Cohoon, Charles Leath Iii, M. Powell, Camille Gunderson-Jackson, K. Moore","doi":"10.1136/ijgc-2022-igcs.14","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":348678,"journal":{"name":"Oral Abstracts (Regular and Late-Breaking Submission)","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Abstracts (Regular and Late-Breaking Submission)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-igcs.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Atezolizumab和bevacizumab治疗复发性子宫内膜癌:一项II期多机构试验
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study LB002/#1545 Late-breaking abstract presentation: comparative effectiveness of HIPEC following interval cytoreductive surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy: multicenter, prospective, cohort study (KGOG 3042) O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial O006/#1066 Randomized trial of pelvic radiation with and without concurrent cisplatin in patients with a pelvic only recurrence of endometrial cancer O007/#456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1